DE69532970D1 - Sprühgetrocknetes erythropoietin - Google Patents

Sprühgetrocknetes erythropoietin

Info

Publication number
DE69532970D1
DE69532970D1 DE69532970T DE69532970T DE69532970D1 DE 69532970 D1 DE69532970 D1 DE 69532970D1 DE 69532970 T DE69532970 T DE 69532970T DE 69532970 T DE69532970 T DE 69532970T DE 69532970 D1 DE69532970 D1 DE 69532970D1
Authority
DE
Germany
Prior art keywords
sprühgetrocknetes
erythropoietin
rhepo
provides
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69532970T
Other languages
English (en)
Other versions
DE69532970T3 (de
DE69532970T2 (de
Inventor
B Mehta
C Corbo
Khurshid Iqbal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23407689&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69532970(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Publication of DE69532970D1 publication Critical patent/DE69532970D1/de
Application granted granted Critical
Publication of DE69532970T2 publication Critical patent/DE69532970T2/de
Publication of DE69532970T3 publication Critical patent/DE69532970T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1816Erythropoietin [EPO]
DE69532970T 1994-12-16 1995-12-15 Sprühgetrocknetes erythropoietin Expired - Lifetime DE69532970T3 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US357947 1982-03-15
US35794794A 1994-12-16 1994-12-16
PCT/US1995/016416 WO1996018647A1 (en) 1994-12-16 1995-12-15 Spray dried erythropoietin
EP95943452A EP0805822B2 (de) 1994-12-16 1995-12-15 Sprühgetrocknetes erythropoietin

Publications (3)

Publication Number Publication Date
DE69532970D1 true DE69532970D1 (en) 2004-06-03
DE69532970T2 DE69532970T2 (de) 2005-06-09
DE69532970T3 DE69532970T3 (de) 2012-02-09

Family

ID=23407689

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69532970T Expired - Lifetime DE69532970T3 (de) 1994-12-16 1995-12-15 Sprühgetrocknetes erythropoietin

Country Status (19)

Country Link
US (2) US6001800A (de)
EP (1) EP0805822B2 (de)
JP (1) JP4039686B2 (de)
CN (1) CN1117762C (de)
AT (1) ATE265468T1 (de)
AU (1) AU697287B2 (de)
CA (1) CA2207615C (de)
DE (1) DE69532970T3 (de)
DK (1) DK0805822T4 (de)
ES (1) ES2219672T5 (de)
FI (1) FI119723B (de)
HU (1) HU222370B1 (de)
IL (1) IL116085A (de)
NO (1) NO319895B1 (de)
NZ (1) NZ298981A (de)
PT (1) PT805822E (de)
TW (1) TW425287B (de)
WO (1) WO1996018647A1 (de)
ZA (1) ZA9510708B (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19539574A1 (de) * 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
US6151332A (en) 1997-06-20 2000-11-21 Tantivy Communications, Inc. Protocol conversion and bandwidth reduction technique providing multiple nB+D ISDN basic rate interface links over a wireless code division multiple access communication system
US6542481B2 (en) 1998-06-01 2003-04-01 Tantivy Communications, Inc. Dynamic bandwidth allocation for multiple access communication using session queues
US6081536A (en) 1997-06-20 2000-06-27 Tantivy Communications, Inc. Dynamic bandwidth allocation to transmit a wireless protocol across a code division multiple access (CDMA) radio link
EP0913177A1 (de) * 1997-11-03 1999-05-06 Roche Diagnostics GmbH Verfahren zur Herstellung trockener, amorpher Produkte enthaltend biologisch aktive Materialien mittels Konvektionstrocknung, insbesondere Sprühtrocknung
US7394791B2 (en) 1997-12-17 2008-07-01 Interdigital Technology Corporation Multi-detection of heartbeat to reduce error probability
US7496072B2 (en) 1997-12-17 2009-02-24 Interdigital Technology Corporation System and method for controlling signal strength over a reverse link of a CDMA wireless communication system
US9525923B2 (en) 1997-12-17 2016-12-20 Intel Corporation Multi-detection of heartbeat to reduce error probability
US6222832B1 (en) 1998-06-01 2001-04-24 Tantivy Communications, Inc. Fast Acquisition of traffic channels for a highly variable data rate reverse link of a CDMA wireless communication system
US7936728B2 (en) 1997-12-17 2011-05-03 Tantivy Communications, Inc. System and method for maintaining timing of synchronization messages over a reverse link of a CDMA wireless communication system
US8134980B2 (en) 1998-06-01 2012-03-13 Ipr Licensing, Inc. Transmittal of heartbeat signal at a lower level than heartbeat request
US7773566B2 (en) 1998-06-01 2010-08-10 Tantivy Communications, Inc. System and method for maintaining timing of synchronization messages over a reverse link of a CDMA wireless communication system
US6526034B1 (en) 1999-09-21 2003-02-25 Tantivy Communications, Inc. Dual mode subscriber unit for short range, high rate and long range, lower rate data communications
AU3673001A (en) 2000-02-07 2001-08-14 Tantivy Communications, Inc. Minimal maintenance link to support synchronization
US8155096B1 (en) 2000-12-01 2012-04-10 Ipr Licensing Inc. Antenna control system and method
US7551663B1 (en) 2001-02-01 2009-06-23 Ipr Licensing, Inc. Use of correlation combination to achieve channel detection
US6954448B2 (en) 2001-02-01 2005-10-11 Ipr Licensing, Inc. Alternate channel for carrying selected message types
ATE361089T1 (de) 2001-02-02 2007-05-15 Ortho Mcneil Pharm Inc Behandlung von neurologischen funktionsstörungen mit fructopyranosesulfamaten und erythropoetin
ES2614202T3 (es) 2001-06-13 2017-05-30 Intel Corporation Método y aparato para la transmisión de una señal de latido de corazón a un nivel inferior que la solicitud de latido de corazón
ATE466085T1 (de) * 2002-09-09 2010-05-15 Hanall Pharmaceutical Co Ltd Protease-resistente modifizierte interferon alpha polypeptide
WO2004060343A1 (en) * 2002-12-31 2004-07-22 Nektar Therapeutics Antibody-containing particles and compositions
KR101233564B1 (ko) 2003-11-14 2013-02-15 추가이 세이야쿠 가부시키가이샤 가교 다당 미립자 및 그 제조 방법
GB2438982A (en) 2004-12-22 2007-12-12 Ambrx Inc Compostions containing, methods involving, and uses of non-natural amino acids and polypeptides
SG160437A1 (en) 2004-12-22 2010-04-29 Ambrx Inc Modified human growth hormone
EP1951890A4 (de) 2005-11-16 2009-06-24 Ambrx Inc Verfahren und zusammensetzungen mit nichtnatürlichen aminosäuren
WO2008030558A2 (en) 2006-09-08 2008-03-13 Ambrx, Inc. Modified human plasma polypeptide or fc scaffolds and their uses
JP2010510794A (ja) 2006-11-28 2010-04-08 ハナル ファーマシューティカル カンパニー リミテッド 修飾型エリスロポエチンポリペプチド及びこの治療用用途
CA2682147C (en) 2007-03-30 2017-08-08 Ambrx, Inc. Modified fgf-21 polypeptides and their uses
BRPI0810622A2 (pt) 2007-05-02 2020-10-13 Ambrx, Inc. polipeptídeos de interferon beta modificados e seus usos
SG2013054218A (en) 2008-01-15 2014-10-30 Abbott Gmbh & Co Kg Powdered protein compositions and methods of making same
NZ591235A (en) 2008-07-23 2012-07-27 Ambrx Inc Modified bovine g-csf polypeptides comprising non natural amino acid and their uses treating infections such as mastitis
PT104350A (pt) 2009-01-23 2010-07-23 Hovione Farmaci Ncia S A Processo de isolamento de tigeciclina
CN104017063A (zh) 2009-12-21 2014-09-03 Ambrx公司 经过修饰的猪促生长素多肽和其用途
CN107674121A (zh) 2009-12-21 2018-02-09 Ambrx 公司 经过修饰的牛促生长素多肽和其用途
TWI480288B (zh) 2010-09-23 2015-04-11 Lilly Co Eli 牛顆粒細胞群落刺激因子及其變體之調配物
JP5913367B2 (ja) 2011-01-05 2016-04-27 ホスピーラ インコーポレイテッド バンコマイシンの噴霧乾燥
WO2013126552A1 (en) 2012-02-21 2013-08-29 Auburn University Buprenorphine nanoparticle composition and methods thereof
CN104043104B (zh) 2013-03-15 2018-07-10 浙江创新生物有限公司 含盐酸万古霉素的喷雾干粉及其工业化制备方法
UY36370A (es) 2014-10-24 2016-04-29 Bristol Myers Squibb Company Una Corporación Del Estado De Delaware Polipéptidos fgf-21 modificados y sus usos
CN104984323B (zh) * 2015-06-12 2018-05-01 北京四环生物制药有限公司 注射用重组人促红素冻干粉针剂
CN105311624A (zh) * 2015-11-23 2016-02-10 哈药集团生物工程有限公司 一种含有重组人促红素的药物组合物
US20220056093A1 (en) 2018-09-11 2022-02-24 Ambrx, Inc. Interleukin-2 polypeptide conjugates and their uses
CN113366015A (zh) 2018-10-19 2021-09-07 Ambrx公司 白细胞介素-10多肽缀合物、其二聚体及其用途
US20220226488A1 (en) 2019-02-12 2022-07-21 Ambrx, Inc. Compositions containing, methods and uses of antibody-tlr agonist conjugates
MX2022011163A (es) 2020-03-11 2022-10-18 Ambrx Inc Conjugados de polipeptidos de interleucina-2 y sus usos.
CA3190606A1 (en) 2020-08-20 2022-02-24 Ambrx, Inc. Antibody-tlr agonist conjugates, methods and uses thereof
CA3213805A1 (en) 2021-04-03 2022-10-06 Feng Tian Anti-her2 antibody-drug conjugates and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57149228A (en) * 1981-03-11 1982-09-14 Ajinomoto Co Inc Novel erythropoietin and its preparation
JPS6197229A (ja) * 1984-10-18 1986-05-15 Chugai Pharmaceut Co Ltd 安定なエリトロポエチン製剤
DE3729863A1 (de) * 1987-09-05 1989-03-16 Boehringer Mannheim Gmbh Stabilisierte erythropoietin-lyophilisate
GB9001987D0 (en) * 1990-01-29 1990-03-28 Janssen Pharmaceutica Nv Improved cyclodextrin based erythropietin formulation
US5354934A (en) * 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin

Also Published As

Publication number Publication date
DE69532970T3 (de) 2012-02-09
MX9704504A (es) 1998-06-30
CA2207615C (en) 2010-12-14
NO972725D0 (no) 1997-06-13
CN1175261A (zh) 1998-03-04
IL116085A0 (en) 1996-01-31
FI119723B (fi) 2009-02-27
AU697287B2 (en) 1998-10-01
JP4039686B2 (ja) 2008-01-30
AU4471396A (en) 1996-07-03
ES2219672T5 (es) 2011-09-26
ES2219672T3 (es) 2004-12-01
ZA9510708B (en) 1997-06-17
NO319895B1 (no) 2005-09-26
US6235710B1 (en) 2001-05-22
FI972557A (fi) 1997-08-14
IL116085A (en) 1999-12-31
CA2207615A1 (en) 1996-06-20
HU222370B1 (hu) 2003-06-28
EP0805822A1 (de) 1997-11-12
NZ298981A (en) 1999-11-29
PT805822E (pt) 2004-08-31
DK0805822T4 (da) 2011-07-11
TW425287B (en) 2001-03-11
DK0805822T3 (da) 2004-08-16
FI972557A0 (fi) 1997-06-16
EP0805822B2 (de) 2011-06-15
DE69532970T2 (de) 2005-06-09
US6001800A (en) 1999-12-14
JPH10511087A (ja) 1998-10-27
EP0805822B1 (de) 2004-04-28
CN1117762C (zh) 2003-08-13
NO972725L (no) 1997-08-06
WO1996018647A1 (en) 1996-06-20
ATE265468T1 (de) 2004-05-15
HUT77811A (hu) 1998-08-28

Similar Documents

Publication Publication Date Title
DE69532970D1 (en) Sprühgetrocknetes erythropoietin
EP0702040A3 (de)
ZA961291B (en) Naphthyl compounds, intermediates, compositions, and methods.
EP0630763A3 (de) Verfahren zum Herstellen von lackierten Teilen.
HK1010196A1 (en) Novel 2,3-dioxo-1,2,3,4-tetrahdro-quinoyxalinyl derivatives.
HUP0002105A3 (en) Method for preparing 1,1,1,3,3-pentachlorobutane
AU1148099A (en) Powder varnish composition, method for producing and the use thereof
EP1023250A4 (de) Verfahren zur herstellung von 2,6-dialkylnaphthalin
ZA974084B (en) Novel α-glucuronidases, production hereof and their uses.
AU2397997A (en) Process for making 4,6-dihydroxypyrimidine
AU2316897A (en) Cyclic imido-1,3,5-triazine crosslinking agents
GB2289682B (en) Self-crosslinking composition,a product obtained from the composition,and method for manufacturing the product
MX9603516A (es) Derivados de oxima y su uso como pesticidas.
EP0653466A3 (de) Pulverlack.
HUP9802316A3 (en) Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same
EP0653246A3 (de) Zerstäuber.
EP0694538A3 (de) 2-Benzyloxy-4-phenoxypyrimidinderivate, Verfahren zu ihrer Herstellung und diese enthaltende herbizide Zusammensetzungen
HUT77004A (hu) Antiaritmiás szerekként felhasználható nitro-benzamidok, előállításuk és ezeket tartalmazó gyógyszerkészítmények
AU7570798A (en) Ionic halomethyl-1,3,5-triazine photoinitiators
ZA978831B (en) Stable, one package coating compositions and process for coating.
EP0680790A3 (de) Pulverdüse.
ZA972302B (en) 1,25-Dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives.
EP0775705A3 (de) Cyclopentenecarboxamid-Derivat, Verfahren zur dessen Herstellung und dabei verwendetes Bicycloamid-Derivat
AU1568895A (en) Process for preparing 2,6-dichloropyridine
AU4715196A (en) Desaminononapeptides, process for preparing the same and their use for preparing elcatonin

Legal Events

Date Code Title Description
8363 Opposition against the patent
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN

R102 Epo decision maintaining patent in amended form now final

Ref document number: 805822

Country of ref document: EP

Effective date: 20110615